125 related articles for article (PubMed ID: 2161233)
1. The IgG, IgM, and IgA isotypes of anti-topoisomerase I and anticentromere autoantibodies.
Hildebrandt S; Weiner E; Senécal JL; Noell S; Daniels L; Earnshaw WC; Rothfield NF
Arthritis Rheum; 1990 May; 33(5):724-7. PubMed ID: 2161233
[TBL] [Abstract][Full Text] [Related]
2. A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera.
Verheijen R; de Jong BA; van Venrooij WJ
Clin Exp Immunol; 1992 Sep; 89(3):456-60. PubMed ID: 1325307
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal study of anticentromere and antitopoisomerase-I isotypes.
Vázquez-Abad D; Russell CA; Cusick SM; Earnshaw WC; Rothfield NF
Clin Immunol Immunopathol; 1995 Mar; 74(3):257-70. PubMed ID: 7859416
[TBL] [Abstract][Full Text] [Related]
4. Isotype analysis of the anti-CENP-B anticentromere autoantibody: evidence for restricted clonality.
Eisenberg RA; Earnshaw WC; Bordwell BJ; Craven SY; Cheek R; Rothfield NF
Arthritis Rheum; 1989 Oct; 32(10):1315-8. PubMed ID: 2508644
[TBL] [Abstract][Full Text] [Related]
5. Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides.
Kuwana M; Medsger TA; Wright TM
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):266-78. PubMed ID: 7554448
[TBL] [Abstract][Full Text] [Related]
6. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
[TBL] [Abstract][Full Text] [Related]
7. Idiotypic analysis of human anti-topoisomerase I autoantibodies.
Hildebrandt S; Noell GS; Vazquez-Abad D; Earnshaw WC; Zanetti M; Rothfield NF
Autoimmunity; 1991; 10(1):41-8. PubMed ID: 1660312
[TBL] [Abstract][Full Text] [Related]
8. IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis.
Martínez-Cordero E; Trejo AP; León DE
J Clin Lab Anal; 2009; 23(6):408-16. PubMed ID: 19927342
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study.
Weiner ES; Hildebrandt S; Senécal JL; Daniels L; Noell S; Joyal F; Roussin A; Earnshaw W; Rothfield NF
Arthritis Rheum; 1991 Jan; 34(1):68-77. PubMed ID: 1845841
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of serum IgG activity correlation against cyclic citrullinated peptide antibodies, topoisomerase I and centromere proteins in Mexican patients with progressive systemic sclerosis].
Rocha-Muñoz AD; González-López L; Peguero-Gómez R; Aguilar-Chávez EA; Villa-Manzano AI; Corona-Sánchez E; Galván-Méndez S; Presiado-Sánchez C; Vázquez-Jiménez JC; Riebeling C; Salazar-Páramo M; Gámez-Nava JI; Nava A
Rev Alerg Mex; 2009; 56(4):103-7. PubMed ID: 19768971
[TBL] [Abstract][Full Text] [Related]
11. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.
García de la Peña-Lefebvre P; Chanseaud Y; Tamby MC; Reinbolt J; Batteux F; Allanore Y; Kahan A; Meyer O; Benveniste O; Boyer O; Guillevin L; Boissier MC; Mouthon L
Clin Immunol; 2004 Jun; 111(3):241-51. PubMed ID: 15183145
[TBL] [Abstract][Full Text] [Related]
12. A long-term longitudinal isotypic study of anti-topoisomerase I autoantibodies.
Hildebrandt S; Jäckh G; Weber S; Peter HH
Rheumatol Int; 1993; 12(6):231-4. PubMed ID: 8387225
[TBL] [Abstract][Full Text] [Related]
13. Isotypic analysis of anti-p53 serum autoantibodies and p53 protein tissue phenotypes in colorectal cancer.
Islam Roney MMS; Lanagan MC; Sheng Y; Gough MM; Snell C; Nguyen NT; Lawler K; Liu C; Lam AK; Kijanka GS
Hum Pathol; 2022 Oct; 128():1-10. PubMed ID: 35750247
[TBL] [Abstract][Full Text] [Related]
14. [Progress in clinical tests and the pathophysiological study of collagen diseases--anti-topoisomerase I antibodies and anticentromere antibodies].
Konndo H
Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2409-13. PubMed ID: 9922659
[No Abstract] [Full Text] [Related]
15. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients.
Weiner ES; Earnshaw WC; Senécal JL; Bordwell B; Johnson P; Rothfield NF
Arthritis Rheum; 1988 Mar; 31(3):378-85. PubMed ID: 2833902
[TBL] [Abstract][Full Text] [Related]
16. Association of Anti-Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti-Topoisomerase I-Positive Systemic Sclerosis.
Boonstra M; Bakker JA; Grummels A; Ninaber MK; Ajmone Marsan N; Wortel CM; Huizinga TWJ; Jordan S; Hoffman-Vold AM; Distler O; Toes REM; Scherer HU; de Vries-Bouwstra JK
Arthritis Rheumatol; 2020 Nov; 72(11):1897-1904. PubMed ID: 32840062
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of anti-topoisomerase I antibody and anti-centromere antibody in diagnosis of collagen diseases].
Takasaki Y
Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1926-31. PubMed ID: 14621581
[No Abstract] [Full Text] [Related]
18. Prevalence of IgM, IgA and IgG rheumatoid factors in juvenile rheumatoid arthritis.
Saulsbury FT
Clin Exp Rheumatol; 1990; 8(5):513-7. PubMed ID: 2261713
[TBL] [Abstract][Full Text] [Related]
19. Correlation between clinical features of systemic lupus erythematosus and levels of antihistone antibodies of the IgG, IgA, and IgM isotypes.
Gompertz NR; Isenberg DA; Turner BM
Ann Rheum Dis; 1990 Jul; 49(7):524-7. PubMed ID: 2383077
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis.
McHugh NJ; James IE; Fairburn K; Maddison PJ
Clin Exp Immunol; 1990 Aug; 81(2):244-9. PubMed ID: 2117509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
